The Relationship Between Diet, Cognition, Stress, and the Gut Microbiota
NMB
1 other identifier
observational
350
1 country
1
Brief Summary
This study aims to investigate the relationship between diet and the microbiota-gut-brain axis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2022
CompletedFirst Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
July 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2025
CompletedSeptember 24, 2024
September 1, 2024
3 years
June 12, 2023
September 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Trait stress/mood: self-report
Self-report questionnaires
Compared at baseline
Trait stress/mood: hypothalamic-pituitary-adrenal axis activity
Cortisol from saliva samples
Compared at baseline
Responses to acute stress: self-report
Self-report questionnaires
Compared at baseline
Responses to acute stress: hypothalamic-pituitary-adrenal axis activity
Cortisol from saliva samples
Compared at baseline
Responses to acute stress: sympathetic-adrenal-medullary pathway activity
Galvanic skin response taken from the skin on the hand
Compared at baseline
Secondary Outcomes (12)
Cognitive performance: working memory
Compared at baseline
Cognitive performance: episodic memory
Compared at baseline
Cognitive performance: decision making
Compared at baseline
Cognitive performance: emotional inhibition
Compared at baseline
Cognitive performance: sustained attention
Compared at baseline
- +7 more secondary outcomes
Study Arms (3)
Low fibre consumers
Healthy adults consuming less than or equal to 18 grams of fibre per day.
Moderate fibre consumers
Healthy adults consuming between 18.1-24.9 grams of fibre per day.
High fibre consumers
Healthy adults consuming greater than or equal to 25 grams of fibre per day.
Interventions
Habitual dietary consumption from a variety of foods will be assessed using 7-day food logs entered by the participant and assessed for accuracy by a dietitian.
Eligibility Criteria
Healthy adult volunteers consuming varying amounts of dietary fibre.
You may qualify if:
- Be able to give written informed consent.
- Be between 18 and 50 years of age.
- Have a body mass index (BMI) between 18.5-29.9 Kg/m2.
- Be in generally good health as determined by the investigator.
You may not qualify if:
- Are less than 18 and greater than 50 years of age.
- Have a BMI below 18.5 or above 29.9 Kg/m2.
- Have a significant acute or chronic coexisting illness \[cardiovascular, gastrointestinal (GI) \[to include functional GI disorders, inflammatory bowel disease, coeliac disease, lactose intolerance, food allergies\], immunological, psychiatric \[to include formal or as determined by MINI Psychiatric interview, diagnosis of current major depression, anxiety disorder, bipolar spectrum disorder, schizophrenia, other DSM-IV Axis I disorder\], neurodevelopmental disorders, immunological, metabolic disorders \[to include type I or II diabetes\], or any condition which contraindicates, in the investigators judgement, entry to the study.
- Have a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk, or confound the interpretation of the study results; all psychoactive medications \[to include anxiolytics, antipsychotics, antidepressants, anticonvulsants, centrally acting corticosteroids, and opioid pain relievers), laxatives, enemas, antibiotics, anti-coagulants, over-the counter non-steroidal anti-inflammatories (NSAIDS). Subjects should have a wash-out period of 4 weeks.
- Current prebiotic or probiotic supplement use (a wash-out period of 4 weeks after cessation will allow entry to the study).
- Females who are peri-menopausal, menopausal or post-menopausal.
- Females who are pregnant or planning a pregnancy, or lactating.
- Participants who are not fluent in English.
- Are colour blind.
- Have dyslexia or dyscalculia.
- Are a current habitual daily smoker.
- Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.
- Subjects receiving treatment involving experimental drugs. If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.
- Have a malignant disease or any concomitant end-stage organ disease.
- Have completed a study in our laboratory in the past 4 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
APC Microbiome Ireland
Cork, T12YT20, Ireland
Biospecimen
Blood, saliva, urine, and stool
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John F Cryan, PhD
APC Microbiome Irealnd
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2023
First Posted
July 5, 2023
Study Start
July 14, 2022
Primary Completion
July 14, 2025
Study Completion
July 14, 2025
Last Updated
September 24, 2024
Record last verified: 2024-09